Neovasc Inc (NVCN) NPV
Neovasc Inc. is a Canada-based medical device company. The Company is developing, manufacturing and marketing products for the rapidly growing cardiovascular marketplace. Its products include Reducer, for the treatment of refractory angina, and Tiara (TM) for the transcatheter treatment of mitral valve disease.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.